StoneCalibre Portfolio Company Anatrace Acquires Modern Reagents and Screens Provider Molecular Dimensions
(Thomson Reuters ONE) -
LOS ANGELES, CA--(Marketwired - February 14, 2017) - StoneCalibre is pleased to
announce that its portfolio company, Anatrace, has completed the acquisition of
Molecular Dimensions Ltd. ("Molecular Dimensions" or the "Company"), a
Cambridge, UK based leading supplier of modern screens, reagents, other
consumables and instrumentation for structural biology research.
"We are pleased to add Molecular Dimensions to the Anatrace family as it
establishes the European presence for the group and further solidifies its
position in the structural biology arena," said Brian Wall, Founder and Chief
Executive Officer of StoneCalibre. "We will continue to look for additional
strategic acquisitions in the life science tools and diagnostics industry that
could enhance the geographic presence, bolster the product and service offering
and complement the organic growth of the companies."
Founded in 1998 to provide specialist products for crystallographers, Molecular
Dimensions has grown through alliances with leading scientists aimed at
developing and commercializing innovative ideas. The Company serves clients
operating in structural biology research across Europe, the Americas and Asia in
universities, research institutes, and blue-chip corporates focused on drug
discovery.
"Most of us may understand that drug discovery is a long and arduous multi-year
process, but what is less known is that many of the specific drug targets are
proteins. With the addition of Molecular Dimensions, we will be able to offer a
more complete portfolio of tools that aid and support drug discovery, disease
prevention and cure," said Ben Travis, Chief Executive Officer of Anatrace. "We
are excited to continue to invest in technologies that remain at the cutting
edge of this evolving industry."
"As I evaluated a variety of potential strategic alternatives for Molecular
Dimensions, it quickly became evident that partnering with Anatrace and
StoneCalibre was the ideal path forward," said Tony Savill, Founder and Managing
Director of Molecular Dimensions. "Their industry expertise, growth-oriented
mind-set and our strategic fit with Anatrace convinced me that Molecular
Dimensions would continue to thrive under their leadership for years to come."
About StoneCalibre
Headquartered in Los Angeles, CA, StoneCalibre is a privately funded investment
firm specializing in the acquisition of lower middle market companies. Founded
by Brian Wall in 2012, StoneCalibre is focused on making investments in both
special situations and quality long-term capital investment opportunities. For
more information please visit our website at www.stonecalibre.com.
About Anatrace
Anatrace is a developer, manufacturer, and distributor of approximately 250
high-purity detergents and synthetic lipids for use in membrane protein research
studies headquartered in Maumee, OH. With nearly 30 years of experience,
Anatrace's products allow researchers to extract, purify, manipulate and
crystallize cell membrane proteins, which serve multiple key functions in a cell
including molecular transport, signal reception and cell adhesion, and account
for approximately 30% of proteins encoded by the human genome. For more
information, visit www.anatrace.com.
For more information please contact:
Nick Matzke
Business Development
StoneCalibre, LLC
Phone: (310) 774-0376
Fax: (310) 427-7448
nmatzke(at)stonecalibre.com
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: StoneCalibre Investments LLC via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Datum: 14.02.2017 - 15:00 Uhr
Sprache: Deutsch
News-ID 524048
Anzahl Zeichen: 4212
contact information:
Town:
Los Angeles, CA
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 335 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"StoneCalibre Portfolio Company Anatrace Acquires Modern Reagents and Screens Provider Molecular Dimensions"
steht unter der journalistisch-redaktionellen Verantwortung von
StoneCalibre Investments LLC (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
